Biotech News
-
Sixth Wave Announces Closing of $6,000,000 Private Placement
March 31, 2021 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave” or the “Company”) is pleased…
-
StageZero Announces 2020 Year End Analyst and Investor Call
March 31, 2021 (Source) — StageZero Life Sciences (“StageZero” or the “Company”) (TSX:SZLS) today announced that it will release…
-
StageZero Announces 2020 Year End Analyst and Investor Call
March 31, 2021 (Source) — StageZero Life Sciences (“StageZero” or the “Company”) (TSX:SZLS) today announced that it will…
-
Perimeter Medical Imaging AI Announces Clinical Study at Northern Arizona Healthcare Verde Valley Medical Center
March 30, 2021 (Source) — Preeminent Breast Cancer Surgeon to Evaluate the Use of Perimeter’s OCT Imaging System During…
-
Rritual Superfoods to Launch Product Line in Rite Aid Stores – Nationwide
March 30, 2021 (Source) — Rritual Superfoods Inc. (“Rritual” or the “Company”) (CSE: RSF; RSF.WT) (FWB: 0RW) is excited to announce…
-
Valeo Pharma Inc. Enters into an Agreement for Enerzair® Breezhaler® and Atectura® Breezhaler® in Canada
March 29, 2021 (Source) — Valeo to commercialize Enerzair® Breezhaler® and Atectura® Breezhaler®, 2 innovative asthma therapies approved by Health Canada…
-
Predictmedix Inc. Announces Engagement of Investment Banking Firm Kingswood Capital Markets
March 29, 2021 (Source) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), a leader in providing AI-powered healthcare solutions…
-
Valeo Pharma to Report First Quarter 2021 Results and Hold Investors Conference Call / Webcast
March 26, 2021 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”),…
-
Perimeter Medical Imaging AI to Present at Lytham Partners Spring 2021 Investor Conference
March 24, 2021 (Source) — Company Presentation at 2:45 p.m. ET on Tuesday, March 30, 2021 Perimeter Medical…
-
Hemostemix Announces Clinical Trial Update and Contract with GlobeX Data to Encrypt its Communications with Regulatory Authorities
March 18, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) is pleased to…
